Cibus (NASDAQ:CBUS) Trading Up 5.1% – Here’s Why

Cibus, Inc. (NASDAQ:CBUS)’s stock price traded up 5.1% on Monday . The company traded as high as $1.43 and last traded at $1.43. Approximately 251,486 shares changed hands during trading, a decline of 7% from the average session volume of 269,288 shares. The stock had previously closed at $1.36.

Analysts Set New Price Targets

A number of analysts have issued reports on the company. Jefferies Financial Group boosted their target price on Cibus from $1.90 to $3.00 and gave the company a “hold” rating in a research report on Wednesday, March 25th. Weiss Ratings lowered Cibus from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Monday. One research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $9.00.

Cibus Stock Performance

The stock has a market capitalization of $108.39 million, a PE ratio of -0.72 and a beta of 1.64. The firm’s 50 day moving average is $1.39 and its two-hundred day moving average is $1.96.

Cibus (NASDAQ:CBUS) last posted its quarterly earnings results on Thursday, May 14th. The company reported ($0.33) EPS for the quarter, missing the consensus estimate of ($0.27) by ($0.06). Cibus had a negative return on equity of 200.87% and a negative net margin of 2,366.33%.The business had revenue of $1.68 million during the quarter, compared to analyst estimates of $1.61 million. On average, analysts anticipate that Cibus, Inc. will post -1.18 EPS for the current year.

Institutional Investors Weigh In On Cibus

Large investors have recently bought and sold shares of the stock. Weiss Asset Management LP acquired a new stake in Cibus in the 1st quarter valued at about $1,758,000. Geode Capital Management LLC grew its position in shares of Cibus by 4.7% during the fourth quarter. Geode Capital Management LLC now owns 275,180 shares of the company’s stock worth $479,000 after buying an additional 12,467 shares in the last quarter. Certior Financial Group LLC grew its position in shares of Cibus by 46.7% during the fourth quarter. Certior Financial Group LLC now owns 271,164 shares of the company’s stock worth $472,000 after buying an additional 86,378 shares in the last quarter. Prescott Group Capital Management L.L.C. purchased a new stake in shares of Cibus during the fourth quarter worth approximately $345,000. Finally, Jane Street Group LLC purchased a new stake in shares of Cibus during the second quarter worth approximately $207,000. Hedge funds and other institutional investors own 33.81% of the company’s stock.

Cibus Company Profile

Cibus, Inc is a biotechnology company specializing in precision gene editing for agricultural applications. Leveraging its proprietary Rapid Trait Development System (RTDS), Cibus develops improved crop traits without the introduction of foreign DNA. The company’s platform enables targeted modifications to plant genomes, allowing for enhanced disease resistance, herbicide tolerance and yield optimization in key row crops.

The company’s core business centers on trait development services and licensing partnerships.